![Marc Dechamps](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Marc Dechamps is currently an Independent Director at OSE Immunotherapeutics SA. Previously, he worked as the Co-Managing Director at Delphi Genetics SA and as the Director & Head of Business Development at eTheRNA immunotherapies NV.
Actieve functies van Marc Dechamps
Bedrijven | Functie | Begin |
---|---|---|
OSE IMMUNOTHERAPEUTICS | Directeur/Bestuurslid | 19-06-2024 |
Eerdere bekende functies van Marc Dechamps
Bedrijven | Functie | Einde |
---|---|---|
Delphi Genetics SA
![]() Delphi Genetics SA BiotechnologyHealth Technology Delphi Genetics SA develops products and technologies for gene cloning and protein expression in bacteria. It offers deoxyribonucleic acid (DNA), antibody development, molecular biology, protein purification, vector adaption, and DNA immunization services. The company was founded by Philippe Gabant, Michel Milinkovitch, and Cedric Szpirer in 2001 and is headquartered in Charleroi, Belgium. | Algemeen Directeur | 01-07-2017 |
eTheRNA immunotherapies NV
![]() eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
OSE IMMUNOTHERAPEUTICS | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Delphi Genetics SA
![]() Delphi Genetics SA BiotechnologyHealth Technology Delphi Genetics SA develops products and technologies for gene cloning and protein expression in bacteria. It offers deoxyribonucleic acid (DNA), antibody development, molecular biology, protein purification, vector adaption, and DNA immunization services. The company was founded by Philippe Gabant, Michel Milinkovitch, and Cedric Szpirer in 2001 and is headquartered in Charleroi, Belgium. | Health Technology |
eTheRNA immunotherapies NV
![]() eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Health Technology |